{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:01:00Z","timestamp":1785330060285,"version":"3.55.0"},"reference-count":28,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Xenobiot.","JoX"],"abstract":"<jats:p>Acute liver failure (ALF) is a fulminant hepatic syndrome characterized by rapid hepatocellular destruction, severe impairment of liver function, and high mortality. Effective pharmacological interventions capable of limiting early hepatic injury remain lacking. Upadacitinib (UPA), a selective inhibitor for Janus kinase 1 (JAK1) with established anti-inflammatory activity, has not previously been investigated in experimental ALF. Consequently, the current study examined the hepatoprotective potential and underlying mechanisms of UPA in a lipopolysaccharide (LPS)\/D-galactosamine (D-GalN)-induced ALF murine model. Mice were pretreated with UPA (10 or 20 mg\/kg) prior to LPS\/D-GalN challenge. UPA significantly attenuated liver injury, as demonstrated by marked reductions in serum ALT, AST, ALP, and \u03b3-GT levels, together with substantial improvement in hepatic histopathology, attenuation of necroinflammation, and reduction in neutrophil accumulation. UPA also restored hepatic redox balance through reduction in lipid peroxidation and nitrosative stress, alongside enhancement of antioxidant capacity. Mechanistically, UPA suppressed IFN-\u03b3\/JAK1\/STAT1 signaling and downregulated NF-\u03baB p65 and inducible nitric oxide synthase (iNOS) expression, with subsequent reduction in hepatic TNF-\u03b1 production. In parallel, UPA inhibited MAPK pathway activation, including ERK1\/2, JNK, and p38 signaling. Moreover, UPA attenuated hepatocellular apoptosis through suppression of active caspase-3 and Bax expression with restoration of Bcl-2 levels. The 20 mg\/kg dose consistently produced greater biochemical, molecular, and histopathological protection than the lower dose. In conclusion, UPA confers significant protection against LPS\/D-GalN-induced ALF through coordinated suppression of oxidative stress, inflammatory signaling, and apoptosis, primarily associated with inhibition of the IFN-\u03b3\/JAK1\/STAT1 and TNF-\u03b1\/NF-\u03baB\/MAPK pathways and modulation of the Bax\/Bcl-2 ratio, underscoring its viability as a promising therapeutic candidate for ALF.<\/jats:p>","DOI":"10.3390\/jox16040140","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:45:14Z","timestamp":1785325514000},"page":"140","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The JAK1 Inhibitor Upadacitinib Curbs Acute Liver Failure via Suppressing IFN-\u03b3\/JAK1\/STAT1 and TNF-\u03b1\/NF-\u03baB\/MAPK Pathways and Modulating Bax\/Bcl-2 Ratio"],"prefix":"10.3390","volume":"16","author":[{"given":"Abdulaziz F.","family":"Alhussaini","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4421-3214","authenticated-orcid":false,"given":"Sara H.","family":"Hazem","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman A.","family":"Saad","sequence":"additional","affiliation":[{"name":"Department of Anatomic Pathology, Faculty of Medicine, Mansoura University, Mansoura 35516, Egypt"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9528-7483","authenticated-orcid":false,"given":"Mahmoud","family":"Elshal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura 35516, Egypt"},{"name":"AlGhad College for Applied Medical Sciences, Najran 66243, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"108840","DOI":"10.5492\/wjccm.v14.i4.108840","article-title":"Management of acute liver failure: An updated literature review","volume":"14","author":"Nagesh","year":"2025","journal-title":"World J. Crit. Care Med."},{"key":"ref_2","first-page":"179","article-title":"Advances in the postoperative care of the liver transplant recipient","volume":"32","author":"Campbell","year":"2026","journal-title":"Curr. Opin. Crit. Care"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1586\/17474124.2016.1127756","article-title":"Current and future directions in the treatment and prevention of drug-induced liver injury: A systematic review","volume":"10","author":"Stine","year":"2016","journal-title":"Expert. Rev. Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/s41598-021-81383-5","article-title":"Co-administration of lipopolysaccharide and D-galactosamine induces genotoxicity in mouse liver","volume":"11","author":"Dong","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BFb0027661","article-title":"Galactosamine hepatitis: Key role of the nucleotide deficiency period in the pathogenesis of cell injury and cell death","volume":"71","author":"Decker","year":"1974","journal-title":"Rev. Physiol. Biochem. Pharmacol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"110811","DOI":"10.1016\/j.jbc.2025.110811","article-title":"Lipopolysaccharide-induced cytokine signaling activates a temporal innate defense program and represses pancreatic \u03b2-cell identity","volume":"301","author":"Bartosiak","year":"2025","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1111\/jgh.70055","article-title":"Hepatic inflammation and liver injury in a model of bacterial infection-triggered acute-on-chronic liver injury","volume":"40","author":"Karatayli","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.166.7.4481","article-title":"IFN-\u03b3\/TNF-\u03b1 synergism as the final effector in autoimmune diabetes: A key role for STAT1\/interferon regulatory factor-1 pathway in pancreatic \u03b2-cell death","volume":"166","author":"Suk","year":"2001","journal-title":"J. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.taap.2015.01.012","article-title":"Genistein modulates the expression of NF-\u03baB and MAPK (p38 and ERK1\/2), thereby attenuating D-galactosamine-induced fulminant hepatic failure in Wistar rats","volume":"283","author":"Ganai","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e13688","DOI":"10.1111\/cts.13688","article-title":"Upadacitinib: Mechanism of action, clinical and translational science","volume":"17","author":"Mohamed","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"150829","DOI":"10.1016\/j.bbrc.2024.150829","article-title":"Upadacitinib counteracts hepatic lipid deposition via the repression of JAK1\/STAT3 signaling and AMPK\/autophagy-mediated suppression of ER stress","volume":"735","author":"Ahn","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.tox.2007.04.021","article-title":"Melatonin attenuates lipopolysaccharide (LPS)-induced apoptotic liver damage in D-galactosamine-sensitized mice","volume":"237","author":"Wang","year":"2007","journal-title":"Toxicology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"106149","DOI":"10.1016\/j.ejps.2022.106149","article-title":"Upadacitinib protects against cisplatin-induced renal and hepatic dysfunction without impairing its anticancer activity","volume":"172","author":"Anbar","year":"2022","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e010831","DOI":"10.1136\/jitc-2024-010831","article-title":"Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion protein","volume":"13","author":"Rotta","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"119618","DOI":"10.1016\/j.lfs.2021.119618","article-title":"Etanercept attenuates immune-mediated hepatitis induced by concanavalin A via differential regulation of the key effector cytokines of CD4+ T cells","volume":"277","author":"Elshal","year":"2021","journal-title":"Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s10787-022-01058-z","article-title":"Escin suppresses immune cell infiltration and selectively modulates Nrf2\/HO-1, TNF-\u03b1\/JNK and IL-22\/STAT3 signaling pathways in concanavalin A-induced autoimmune hepatitis in mice","volume":"30","author":"Elshal","year":"2022","journal-title":"Inflammopharmacology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: Open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"105808","DOI":"10.1016\/j.intimp.2019.105808","article-title":"Retinoic acid modulates IL-4, IL-10 and MCP-1 pathways in immune-mediated hepatitis and interrupts CD4+ T-cell infiltration","volume":"75","author":"Elshal","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ling, S., Diao, H., Lu, G., and Shi, L. (2024). Associations between serum levels of liver function biomarkers and all-cause and cause-specific mortality: A prospective cohort study. BMC Public Health, 24.","DOI":"10.1186\/s12889-024-20773-6"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00011-014-0720-x","article-title":"Oxidative stress promotes D-GalN\/LPS-induced acute hepatotoxicity by increasing glycogen synthase kinase 3\u03b2 activity","volume":"63","author":"Wei","year":"2014","journal-title":"Inflamm. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41401-020-00597-x","article-title":"Deletion of TLR4 attenuates lipopolysaccharide-induced acute liver injury by inhibiting inflammation and apoptosis","volume":"42","author":"Chen","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s43556-023-00151-1","article-title":"JAK-STAT signaling in inflammation and stress-related diseases: Implications for therapeutic interventions","volume":"4","author":"Sarapultsev","year":"2023","journal-title":"Mol. Biomed."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1007\/s12325-025-03291-8","article-title":"Interferon in liver diseases: Recent advances","volume":"42","author":"Gao","year":"2025","journal-title":"Adv. Ther."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"12533","DOI":"10.2147\/JIR.S535747","article-title":"Upadacitinib attenuates lipopolysaccharide- and cecal ligation and puncture-induced inflammatory responses by inhibiting NF-\u03baB and its downstream cytokines","volume":"18","author":"Yao","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jsps.2023.01.005","article-title":"Crosstalk of TNF-\u03b1, IFN-\u03b3, NF-\u03baB, STAT1 and redox signaling in lipopolysaccharide\/D-galactosamine\/dimethylsulfoxide-induced fulminant hepatic failure in mice","volume":"31","author":"Alanazi","year":"2023","journal-title":"Saudi Pharm. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","article-title":"NF-\u03baB in inflammation and cancer","volume":"22","author":"Mao","year":"2025","journal-title":"Cell Mol. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.3748\/wjg.v23.i21.3839","article-title":"Inhibitory effect of oxymatrine on hepatocyte apoptosis via TLR4\/PI3K\/Akt\/GSK-3\u03b2 signaling pathway","volume":"23","author":"Zhang","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/ptr.7407","article-title":"Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-\u03baB, JAK\/STAT and MAPK signaling pathways","volume":"36","author":"Haftcheshmeh","year":"2022","journal-title":"Phytother. Res."}],"container-title":["Journal of Xenobiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2039-4713\/16\/4\/140\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T12:09:17Z","timestamp":1785326957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2039-4713\/16\/4\/140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jox16040140"],"URL":"https:\/\/doi.org\/10.3390\/jox16040140","relation":{},"ISSN":["2039-4713"],"issn-type":[{"value":"2039-4713","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}